Evidence map›Paper›PMID 38059527›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2024

Rapid Environmental Contamination With Candida auris and Multidrug-Resistant Bacterial Pathogens Near Colonized Patients.

Sarah E Sansom, Gabrielle M Gussin, Michael Schoeny, Raveena D Singh, Hira Adil, Pamela Bell, Ellen C Benson, Cassiana E Bittencourt, Stephanie Black, Maria Del Mar Villanueva Guzman and 18 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Methods for skin load reduction of Candida auris: a systematic review.Antimicrobial resistance and infection control · 2026
    Pooled it
  2. Transfer ofOpen forum infectious diseases · 2026
    Article
  3. Active Screening forJournal of fungi (Basel, Switzerland) · 2026
    Review
  4. Multicenter performance evaluation of the SimplexaJournal of clinical microbiology · 2026
    Article
  5. Article
  6. Article
  7. Can Chlorhexidine Bathing Reduce Candidozyma auris Shedding?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Isolation of a multidrug-resistantMedical mycology case reports · 2026
    Article
  12. Review
  13. Infection control and hospital epidemiology · 2026
    Article
  14. bioRxiv : the preprint server for biology · 2026
    Article
  15. Infection prevention and control ofAntimicrobial stewardship & healthcare epidemiology : ASHE · 2026
    Review
  16. Outcomes of patients withAntimicrobial stewardship & healthcare epidemiology : ASHE · 2026
    Article
  17. Review
  18. Nasal Iodophor to ReduceOpen forum infectious diseases · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 5 institutions in 1 country.

Sarah E SansomDivision of Infectious Diseases, Rush University Medical Center, Chicago Illinois, USA.ORCID 0000-0002-1924-8941
Gabrielle M GussinDivision of Infectious Diseases, University of California, Irvine School of Medicine, Irvine California, USA.ORCID 0000-0001-8051-7613
Michael SchoenyCollege of Nursing, Rush University Medical Center, Chicago Illinois, USA.ORCID 0000-0002-3066-708X
Raveena D SinghDivision of Infectious Diseases, University of California, Irvine School of Medicine, Irvine California, USA.
Hira AdilDisease Control Bureau, Chicago Department of Public Health, Chicago Illinois, USA.ORCID 0009-0008-0864-1458
Pamela BellDivision of Infectious Diseases, Rush University Medical Center, Chicago Illinois, USA.
Ellen C BensonDivision of Infectious Diseases, Rush University Medical Center, Chicago Illinois, USA.
Cassiana E BittencourtDepartment of Pathology and Laboratory Medicine, University of California, Irvine School of Medicine, Irvine California, USA.
Stephanie BlackDisease Control Bureau, Chicago Department of Public Health, Chicago Illinois, USA.
Maria Del Mar Villanueva GuzmanDivision of Infectious Diseases, Rush University Medical Center, Chicago Illinois, USA.
Mary Carl FroilanDivision of Infectious Diseases, Rush University Medical Center, Chicago Illinois, USA.
Christine FukudaDivision of Infectious Diseases, Rush University Medical Center, Chicago Illinois, USA.
Karina BarsegyanDivision of Infectious Diseases, University of California, Irvine School of Medicine, Irvine California, USA.
Ellen GoughDivision of Infectious Diseases, Rush University Medical Center, Chicago Illinois, USA.ORCID 0009-0005-8202-4843
Meghan LymanMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta Georgia, USA.
Jinal MakhijaDivision of Infectious Diseases, Rush University Medical Center, Chicago Illinois, USA.ORCID 0000-0002-6931-5188
Stefania MarronDivision of Infectious Diseases, Rush University Medical Center, Chicago Illinois, USA.
Lydia MikhailDivision of Epidemiology and Assessment, Orange County Health Care Agency, Santa Ana, California, USA.
Judith Noble-WangDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta Georgia, USA.
Massimo PacilliDisease Control Bureau, Chicago Department of Public Health, Chicago Illinois, USA.ORCID 0000-0002-6638-0961
Robert PedrozaDivision of Infectious Diseases, University of California, Irvine School of Medicine, Irvine California, USA.
Raheeb SaavedraDivision of Infectious Diseases, University of California, Irvine School of Medicine, Irvine California, USA.
D Joseph SextonMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta Georgia, USA.
Julie ShimabukuroDepartment of Pathology and Laboratory Medicine, University of California, Irvine School of Medicine, Irvine California, USA.
Lahari ThotapalliDivision of Infectious Diseases, Rush University Medical Center, Chicago Illinois, USA.
Matthew ZahnDivision of Epidemiology and Assessment, Orange County Health Care Agency, Santa Ana, California, USA.
Susan S HuangDivision of Infectious Diseases, University of California, Irvine School of Medicine, Irvine California, USA.
Mary K HaydenDivision of Infectious Diseases, Rush University Medical Center, Chicago Illinois, USA.ORCID 0000-0002-4603-8501
Rush University Medical Center · USUniversity of California, Irvine · USCenters for Disease Control and Prevention · USChicago Department of Public Health · USOrange County Healthcare Agency · US

Funding

NCEZID CDC HHS U54 CK000607
6 · The paper itself

Abstract

backgroundEnvironmental contamination is suspected to play an important role in Candida auris transmission. Understanding speed and risks of contamination after room disinfection could inform environmental cleaning recommendations.

methodsWe conducted a prospective multicenter study of environmental contamination associated with C. auris colonization at 6 ventilator-capable skilled nursing facilities and 1 acute care hospital in Illinois and California. Known C. auris carriers were sampled at 5 body sites followed by sampling of nearby room surfaces before disinfection and at 0, 4, 8, and 12 hours after disinfection. Samples were cultured for C. auris and bacterial multidrug-resistant organisms (MDROs). Odds of surface contamination after disinfection were analyzed using multilevel generalized estimating equations.

resultsAmong 41 known C. auris carriers, colonization was detected most frequently on palms/fingertips (76%) and nares (71%). C. auris contamination was detected on 32.2% (66/205) of room surfaces before disinfection and 20.5% (39/190) of room surfaces by 4 hours after disinfection. A higher number of C. auris-colonized body sites was associated with higher odds of environmental contamination at every time point following disinfection, adjusting for facility of residence. In the rooms of 38 (93%) C. auris carriers co-colonized with a bacterial MDRO, 2%-24% of surfaces were additionally contaminated with the same MDRO by 4 hours after disinfection.

conclusionsC. auris can contaminate the healthcare environment rapidly after disinfection, highlighting the challenges associated with environmental disinfection. Future research should investigate long-acting disinfectants, antimicrobial surfaces, and more effective patient skin antisepsis to reduce the environmental reservoir of C. auris and bacterial MDROs in healthcare settings.

Indexed as

Candida aurisDrug Resistance, Multiple, BacterialAgedBacteriaCaliforniaCandidiasisCarrier StateCross InfectionDisinfectionEnvironmental MicrobiologyFemaleHumansMaleMiddle AgedProspective StudiesCandida auriscolonizationdisinfectionenvironmental contamination

Identifiers

PMID38059527
PMCPMC11093678
OpenAlexW4389430943

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.